Mayne earnings outlook rosy despite threat of Trump tariffs
MELBOURNE: Drugmaker Mayne Pharma, which is the subject of a $672m foreign takeover bid, has
MELBOURNE: Drugmaker Mayne Pharma, which is the subject of a $672m foreign takeover bid, has
FEATURED
New apartments are helping transform the treatment experience
Plan unveiled to replace former care home with 24 modern retirement flats
Modernist architecture now set to meet affordable housing for seniors
Land carve-ups help build better housing future for remote communities
Best retirement housing design for Global Awards shortlisted
Boomers high-rise set to come with a health hub
INNOVATION
